Combinatorial BRAFi and VEGFA removal reshapes the TME maximizing the anticancer effects of ICB therapies, suggesting that VEGFA neutralization represents a further option to improve targeted therapy and immunotherapy in melanoma. Here, VEGFA is linked to melanoma.